Kaplan–Meier curves were obtained (Figure 4 and Figure 5) and the survival analysis was fitted into a Cox proportional hazard model with the data variables of age, sex, presence of other cancer, number of surgical resections, tumor location, bevacizumab treatment, and MGMT promoter methylation status. This evidence concerns the gene MGMT and cancer.